Literature DB >> 17491686

Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.

Lucienne Chatenoud, Jean-François Bach.   

Abstract

Entities:  

Year:  2005        PMID： 17491686      PMCID： PMC1783560          DOI： 10.1900/RDS.2005.2.116

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN： 1613-6071


× No keyword cloud information.
  42 in total

1.  Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.

Authors:  Roger Assan; Françoise Blanchet; Gilles Feutren; José Timsit; Etienne Larger; Christian Boitard; Claude Amiel; Jean-François Bach
Journal:  Diabetes Metab Res Rev       Date:  2002 Nov-Dec       Impact factor: 4.876

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

Review 3.  CD40/CD154 interactions at the interface of tolerance and immunity.

Authors:  Sergio A Quezada; Lamis Z Jarvinen; Evan F Lind; Randolph J Noelle
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 4.  A comprehensive review of interventions in the NOD mouse and implications for translation.

Authors:  Lisl K M Shoda; Daniel L Young; Saroja Ramanujan; Chan C Whiting; Mark A Atkinson; Jeffrey A Bluestone; George S Eisenbarth; Diane Mathis; Aldo A Rossini; Scott E Campbell; Richard Kahn; Huub T C Kreuwel
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

5.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

6.  Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.

Authors:  E Strandell; D L Eizirik; S Sandler
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.

Authors:  Mériam Belghith; Jeffrey A Bluestone; Samia Barriot; Jérôme Mégret; Jean-François Bach; Lucienne Chatenoud
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

8.  Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody.

Authors:  M R Nicolls; G G Aversa; N W Pearce; A Spinelli; M F Berger; K E Gurley; B M Hall
Journal:  Transplantation       Date:  1993-03       Impact factor: 4.939

9.  Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice.

Authors:  P Sempé; P Bédossa; M F Richard; M C Villà; J F Bach; C Boitard
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

10.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Authors:  J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307
View more
  2 in total

1.  Limitations in immunotherapy with CD3 antibodies: comment on the article by Drs. Chatenoud and Bach.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Rev Diabet Stud       Date:  2006-02-10

2.  "Persistence of Diabetes" - Why Has Research into Type 1 Diabetes not Made Significant Advances?

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2007-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.